Malaria Drug Shortages in Kenya: A Major Failure to Provide Access to Effective Treatment
Open Access
- 1 May 2009
- journal article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 80 (5) , 737-738
Abstract
A key bench mark of successful therapeutic policy implementation, and thus effectiveness, is that the recommended drugs are available at the point of care. Two years after artemether-lumefathrine (AL) was introduced for the management of uncomplicated malaria in Kenya, we carried out a cross-sectional survey to investigate AL availability in government facilities in seven malaria-endemic districts. One of four of the surveyed facilities had none of the four AL weight-specific treatment packs in stock; three of four facilities were out of stock of at least one weight-specific AL pack, leading health workers to prescribe a range of inappropriate alternatives. The shortage was in large part caused by a delayed procurement process. National ministries of health and the international community must address the current shortcomings facing antimalarial drug supply to the public sector.Keywords
This publication has 9 references indexed in Scilit:
- Malaria case-management under artemether-lumefantrine treatment policy in UgandaMalaria Journal, 2008
- Health facility and health worker readiness to deliver new national treatment policy for malaria in KenyaEast African Medical Journal, 2008
- A Major Transition in Malaria Treatment: The Adoption and Deployment of Artemisinin-Based Combination TherapiesThe American Journal of Tropical Medicine and Hygiene, 2007
- The challenges of changing national malaria drug policy to artemisinin-based combinations in KenyaMalaria Journal, 2007
- Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional studyMalaria Journal, 2007
- The process of changing national malaria treatment policy: lessons from country-level studiesHealth Policy and Planning, 2004
- History, Dynamics, and Public Health Importance of Malaria Parasite ResistanceClinical Microbiology Reviews, 2004
- WHO, the Global Fund, and medical malpractice in malaria treatmentThe Lancet, 2004
- Using evidence to change antimalarial drug policy in KenyaTropical Medicine & International Health, 2000